Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function

Blood

Volumn 92, Issue 9, 1998, Pages 3388-3393

  Krieg, Marion ^b   Marti, Hugo H ^b   Plate, Karl H ^a  

^a Abteilung Neuropathologie

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION; GENE REPRESSION; HEMANGIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0032211161     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3388.421a09_3388_3393     Document Type: Article

References (41)

1. Koury MJ, Bondurant MC: The molecular mechanism of erythropoietin action. Eur J Biochem 210:649, 1992
2. Jelkmann W: Erylhropoietin: Structure, control of production, and function. Physiol Rev 72:449, 1992
3. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M: Erythropoietin gene expression in human monkey and murine brain. Eur J Neurosci 8:666, 1996
4. Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, Trentz O, Bauer C: Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain. Kidney Int 51:416, 1997
5. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M: Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717, 1995
6. Tan CC, Eckardt K-U, Firth JD, Ratcliffe PJ: Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 263:F474, 1992 (suppl)
7. Stratmann R, Krieg M, Haas R, Plate KH: Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol 56:1242, 1997
8. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, Zhuang Z: Von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540, 1997
9. Wizigmann-Voos S, Plate KH: Pathology, genetics and cell biology of hemangioblastomas. Histol Histopathol 11:1049, 1996
10. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845, 1994
11. Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA: Negative regulation of hypoxia-inducible genes by the von Hippel- Lindau protein. Proc Natl Acad Sci USA 93:10595, 1996
12. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D: Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299, 1996
13. Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner R, Linehan WM: Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 93:10589, 1996
14. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clar WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153, 1993
15. Samato K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189, 1995
16. Wizigmann-Voos S, Breier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel- Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55:1358, 1995
17. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843, 1992
18. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845, 1992
19. Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57:3860, 1997
20. Goldberg MA, Gaut CC, Bunn HF: Erythropoietin mRNA levels are governed by both rate of gene transcription and posttranscriptional events. Blood 77:271, 1991
21. Goldberg MA, Schneider TJ: Similarities between the oxygen- sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355, 1994
22. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcript ion al activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270:19761, 1995
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
24. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell proliferation. Development 114:521, 1992
25. Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Mahler ER: Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors. Am J Hum Genet 60:765, 1997
26. Tachibana O, Yamashima T, Yamashita J: Immunohistochemical study of erythropoietin in cerebellar hemangioblastomas associated with secondary polycythemia. Neurosurgery 28:24, 1991
27. Anagnostou A, Chawla MS, Pololi L, Fried W: Determination of plasma erythropoietin levels: An early marker of tumor activity. Cancer 44:1014, 1979
28. Jeffreys RV, Napier JAF, Reynolds SH: Erythropoietin levels in posterior fossa hemangioblastomas. J Neurol Neurosurg Psychiatry 45:264, 1982
29. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R: A novel site of erythropoietin production: Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269:19488, 1994
30. Trimble M, Caro J, Talalla A, Brain M: Secondary erythrocytosis is due to a cerebellar hemangioblastoma; Demonstration of erythropoietin mRNA in the tumor. Blood 78:599, 1991
31. Bruneval P, Sassy C, Mayeux P, Belair M-F, Casadevall N, Roux F-X, Varet B, Lacombe C: Erythropoietin synthesis by tumor cells in a case of meningioma associated with erythrocytosis. Blood 81:1593, 1993
32. Waldmann TA, Levin EH, Baldwin M: The association of polycythemia with cerebellar hemangioblastoma. Am J Med 31:318, 1961
33. Zee N, Cera P, Towfighi J: Extramedullary hematopoiesis in cerebellar hemangioblastomas. Neurosurgery 29:34, 1991
34. Ohyagi Y, Yamada T, Goto I: Hemoglobin as a novel protein developmentally regulated in neurons. Brain Res 635:323, 1994
35. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y: Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 239:494, 1996
36. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978, 1990
37. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974, 1994
38. Carlini RG, Reyes AA, Rothstein M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47:740, 1995
39. Da Silva J-L, Lacombe C, Bruneval P, Casadevall N, Leporrier M, Camilleri J-P, Bariety J, Tambourin P, Varet B: Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood 75:577, 1990
40. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255, 1993
41. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85, 1994